I will support legislation to lower the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs by establishing a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status.

Senators Curtis and Rosen introduced a bill to help reduce the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs. Their bipartisan Expanding Access to Affordable Prescription Drugs and Medical Devices Act will create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status, to support this critical industry and bolster nonprofit manufacturer production so more Americans can have access to lower cost medicine.

Curtis introduced legislation to reduce costs of prescription drugs and medical devices, prevent shortages, boost domestic production and jobs, and grant nonprofit manufacturers tax-exempt status.

Press Releases - Senator John Curtis
primary · press_release · model gpt-4.1

"Utahns and their families look to Congress to help cut red tape and streamline innovation, and alongside Senator Rosen, this legislation will help secure the domestic supply chain and empower nonprofit manufacturers to improve our most vulnerable health care markets."

Curtis backs the bipartisan bill to lower prescription drug and medical device costs, reduce shortages, strengthen domestic production, and support nonprofit manufacturers.

Curtis, Rosen Introduce Bipartisan Bill to Lower Costs of Medications, Medical Devices - Senator John Curtis
primary · press_release · model gpt-5.4-mini

The member page lists S.3325, "Expanding Access to Affordable Drugs and Medical Devices Act," with latest action "Senate - 12/03/2025 Read twice and referred to the Committee on Finance."

Official congressional record shows the bill was introduced and referred, with no later action shown on the member page through the current review date; the commitment remains unresolved.

unresolved same_term

John R. Curtis | Congress.gov | Library of Congress
secondary · model gpt-5.4-mini · confidence 96%

The press release says Senators Rosen and Curtis introduced a bipartisan bill that would "create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status" and lower costs of prescription drugs and medical devices.

This confirms concrete legislative effort consistent with the promise, but it is introduction-stage activity rather than delivery; there is no evidence in the lookback window of enactment, committee advancement, or executive implementation.

partial same_term A for effort

Curtis, Rosen Introduce Bipartisan Bill to Lower Costs of Medications, Medical Devices - Senator John Curtis
primary · model gpt-5.4-mini · confidence 92%

Curtis's Senate office said Senators Jacky Rosen and John Curtis introduced a bipartisan bill to reduce prescription-drug and medical-device costs, prevent shortages, boost domestic production, create jobs, and create a pathway for nonprofit manufacturers to receive tax-exempt status.

This directly confirms Curtis supported and introduced legislation matching the promise during his Senate term. Because the promise was to support such legislation, this supports fulfillment even though the bill was not shown as enacted.

delivered same_term

Curtis, Rosen Introduce Bipartisan Bill to Lower Costs of Medications, Medical Devices - Senator John Curtis
primary · model gpt-5.5 · confidence 94%

Congress.gov lists S.3325, the Expanding Access to Affordable Drugs and Medical Devices Act, sponsored by Sen. Jacky Rosen, with one cosponsor, referred to the Senate Finance Committee on December 3, 2025, and status Introduced.

The official bill record verifies that the relevant legislation existed in the 119th Congress and had not advanced beyond introduction and referral. This supports delivery of the support pledge when paired with Curtis's official announcement, but not enactment of the policy.

delivered same_term

S.3325 - 119th Congress (2025-2026): Expanding Access to Affordable Drugs and Medical Devices Act | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 90%

The Congress.gov member page for John R. Curtis lists S.3325, Expanding Access to Affordable Drugs and Medical Devices Act, with latest action: read twice and referred to the Senate Finance Committee on December 3, 2025.

Curtis's official Congress.gov member record includes the bill, confirming the action occurred during his Senate service. The same entry shows only introduced-stage status, so it does not prove enactment.

delivered same_term

John R. Curtis | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 88%

Congress.gov describes S.3325 as a bill to amend the Internal Revenue Code to provide rules for tax-exempt status of organizations that manufacture and distribute drugs and medical devices to meet public health needs; text had not been received as of December 23, 2025.

The official text page confirms the bill's subject matches the promised tax-exempt pathway for nonprofit drug and medical-device manufacturers, while also showing that formal legislative text was not yet available on Congress.gov at that point.

delivered same_term

Text - S.3325 - 119th Congress (2025-2026): A bill to amend the Internal Revenue Code of 1986 to provide rules for determining the tax-exempt status of organizations that manufacture and distribute drugs and medical devices to meet public health needs, and for other purposes. | Congress.gov | Library of Congress
secondary · model gpt-5.5 · confidence 86%